Roanna Ruiz Initiated (AVIR) at Buy and Held Target at $60 on, Sep 9th, 2021
Roanna Ruiz of SVB Leerink, Initiated "Atea Pharmaceuticals, Inc." (AVIR) at Buy and Held Target at $60 on, Sep 9th, 2021.
Roanna has made no other calls on AVIR in the last 4 months.
There is 1 other peer that has a rating on AVIR. Out of the 1 peers that are also analyzing AVIR, 0 agree with Roanna's Rating of Hold.
This is the rating of the analyst that currently disagrees with Roanna
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $37 on, Wednesday, August 18th, 2021